<?xml version="1.0" encoding="UTF-8"?>
<p>Over the past three decades, researchers have consistently documented an array of sexual behaviors among MSM that have contributed to this key population’s high risk for HIV infection[
 <xref rid="pone.0200816.ref003" ref-type="bibr">3</xref>]. However, new evidence from Europe [
 <xref rid="pone.0200816.ref005" ref-type="bibr">5</xref>], North America [
 <xref rid="pone.0200816.ref006" ref-type="bibr">6</xref>], Australia [
 <xref rid="pone.0200816.ref007" ref-type="bibr">7</xref>], and Asia [
 <xref rid="pone.0200816.ref008" ref-type="bibr">8</xref>], suggests that drug use is further elevating the risk for HIV infection for this vulnerable population [
 <xref rid="pone.0200816.ref009" ref-type="bibr">9</xref>–
 <xref rid="pone.0200816.ref011" ref-type="bibr">11</xref>]. While drug use among MSM has historically involved the use of stimulants (e.g., ecstasy) or dissociatives (e.g., ketamine), other synthetic drugs such as methamphetamine, mephedrone, and alkyl nitrites (so-called “poppers”) are becoming more popular since users tend to experience both stimulant and sexual effects—disinhibition and euphoria combined with enhanced libido, arousal, and pleasure[
 <xref rid="pone.0200816.ref009" ref-type="bibr">9</xref>, 
 <xref rid="pone.0200816.ref010" ref-type="bibr">10</xref>].
</p>
